Logo of Adherium (ASX:ADR)Latest Adherium (ASX:ADR) News

Page 4
Page 4 of 4

Adherium Secures $900K to Accelerate US Roll-Out of Hailie® Smartinhaler®

Adherium Limited has locked in $900,000 through convertible notes to fund the expansion of its Hailie® Smartinhaler® platform in the US, pending shareholder approval at the upcoming AGM.
Ada Torres
19 May 2025

Adherium Doubles US Patient Base, Launches New Smartinhaler, Plans Capital Raise

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.
Ada Torres
30 Apr 2025

Adherium Accelerates US Growth with Nearly 3,000 Patients Using Hailie® Smartinhaler™

Adherium reports strong patient adoption and new US partnerships, positioning for significant expansion in 2025 with a target of 9,000 active users and entry into the Pharmacy Benefit Management sector.
Ada Torres
31 Jan 2025